NO149135C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-cykloalkanooksazepiner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-cykloalkanooksazepiner

Info

Publication number
NO149135C
NO149135C NO793421A NO793421A NO149135C NO 149135 C NO149135 C NO 149135C NO 793421 A NO793421 A NO 793421A NO 793421 A NO793421 A NO 793421A NO 149135 C NO149135 C NO 149135C
Authority
NO
Norway
Prior art keywords
pct
preparation
cycloalkanooksazepines
therapeutically active
date
Prior art date
Application number
NO793421A
Other languages
English (en)
Norwegian (no)
Other versions
NO149135B (no
NO793421L (no
Inventor
Hans Joerg Treiber
Dieter Lenke
Wolfgang Worstmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO793421L publication Critical patent/NO793421L/no
Publication of NO149135B publication Critical patent/NO149135B/no
Publication of NO149135C publication Critical patent/NO149135C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Epoxy Resins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Hydrogenated Pyridines (AREA)
NO793421A 1978-10-26 1979-10-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-cykloalkanooksazepiner NO149135C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782846567 DE2846567A1 (de) 1978-10-26 1978-10-26 Neue 1,4-cycloalkanooxazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO793421L NO793421L (no) 1980-04-29
NO149135B NO149135B (no) 1983-11-14
NO149135C true NO149135C (no) 1984-02-29

Family

ID=6053137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO793421A NO149135C (no) 1978-10-26 1979-10-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-cykloalkanooksazepiner

Country Status (23)

Country Link
US (1) US4336263A (ja)
EP (2) EP0010717B1 (ja)
JP (1) JPS6321670B2 (ja)
AT (1) ATE4711T1 (ja)
AU (1) AU531189B2 (ja)
CA (1) CA1113090A (ja)
CS (1) CS208458B2 (ja)
DD (1) DD145915A5 (ja)
DE (2) DE2846567A1 (ja)
DK (1) DK150854C (ja)
ES (1) ES485350A1 (ja)
FI (1) FI66365C (ja)
GR (1) GR65676B (ja)
HU (1) HU177947B (ja)
IE (1) IE49089B1 (ja)
IL (1) IL58502A (ja)
NO (1) NO149135C (ja)
PL (1) PL115744B2 (ja)
PT (1) PT70348A (ja)
SU (1) SU799663A3 (ja)
WO (1) WO1980000838A1 (ja)
YU (1) YU261379A (ja)
ZA (1) ZA795716B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52502B1 (en) * 1981-03-27 1987-11-25 Wyeth John & Brother Ltd Morpholines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3598808A (en) * 1968-09-03 1971-08-10 Upjohn Co Perhydro-5-phenyl-cycloalkapolyene-1,4-oxazepines and their preparations
AT336026B (de) * 1975-03-12 1977-04-12 Broschek G Chem Prod Gebro Verfahren zur herstellung von neuen 1,4-oxazepinen bzw. -diazepinen

Also Published As

Publication number Publication date
NO149135B (no) 1983-11-14
IE792014L (en) 1980-04-26
FI66365B (fi) 1984-06-29
FI66365C (fi) 1984-10-10
EP0010717B1 (de) 1983-09-21
EP0020515A1 (de) 1981-01-07
PL115744B2 (en) 1981-04-30
CA1113090A (en) 1981-11-24
PL219169A2 (ja) 1980-08-11
JPS55500865A (ja) 1980-10-30
DE2966199D1 (en) 1983-11-10
ZA795716B (en) 1980-11-26
WO1980000838A1 (en) 1980-05-01
IL58502A0 (en) 1980-01-31
EP0010717A1 (de) 1980-05-14
YU261379A (en) 1983-10-31
IL58502A (en) 1982-12-31
ES485350A1 (es) 1980-05-16
DD145915A5 (de) 1981-01-14
DK272080A (da) 1980-06-25
SU799663A3 (ru) 1981-01-23
DK150854B (da) 1987-07-06
ATE4711T1 (de) 1983-10-15
IE49089B1 (en) 1985-07-24
HU177947B (en) 1982-02-28
AU5214479A (en) 1980-05-01
US4336263A (en) 1982-06-22
NO793421L (no) 1980-04-29
FI793231A (fi) 1980-04-27
AU531189B2 (en) 1983-08-11
GR65676B (en) 1980-10-17
PT70348A (de) 1979-11-01
JPS6321670B2 (ja) 1988-05-09
DE2846567A1 (de) 1980-05-08
DK150854C (da) 1988-02-29
CS208458B2 (en) 1981-09-15

Similar Documents

Publication Publication Date Title
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
ES2038623T3 (es) Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.
NO149135C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-cykloalkanooksazepiner
NO158677C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol-derivater.
ES8607941A1 (es) Procedimiento para la obtencion de 1-fenil-3-azabiciclo (3,1,0)hexan-2,4-dionas sustituidas
NO910033D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
AU527523B2 (en) Hexahydro-1,4-oxazepines
NO166444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloheptaner.
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
ES2061722T3 (es) Derivados de fenantridina, procedimiento para su obtencion y agentes para la realizacion del procedimiento.
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.